SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-guided quarterly results and upbeat 2027 EBITDA outlook have driven a sharp rally, with traders debating whether short covering could extend the move. Bulls see improving steel operations and prices, while skeptics question whether the outlook can overcome the companys debt and reliance on favorable steel markets; some also warn the rally could fade.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention amid a steep selloff, with traders pointing to scheduled lockup expirations and potential insider-share supply, alongside concerns about its IPO valuation, growth and ability to scale. The debate pits bearish calls for further declines against dip-buyers who remain bullish on Cerebras AI-inference technology and long-term demand.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs Buy upgrade after a sharp selloff is driving attention, but traders are split after the initial pop faded: some see an oversold buying opportunity, while others remain concerned about CoreWeaves heavy debt and financing costs.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broad neocloud and AI-infrastructure selloff as traders focus on financing costs, debt concerns and doubts about the sectors business models, with CoreWeaves credit worries adding to contagion fears. The community is split on whether sharp rebounds are durable or bull traps: bulls point to Nebiuss comparatively stronger balance sheet and long-term compute demand, while bears question the capital intensity and path to profitability.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are under pressure after a prolonged decline, with traders frequently blaming insider share sales and frustration that management has not announced a fresh buyback. Some see the selloff as a buying opportunity given the companys growth and cash position, while others warn the stock may keep falling and question its valuation and management.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

FDA expanded ANKTIVA plus BCG to cover papillary-only BCG-unresponsive bladder cancer, broadening its potential market; traders also focused on long-term Phase 3 data showing durable responses and bladder-sparing outcomes. Despite bullish views on the commercial opportunity, the shares sold off, with the community debating a sell-the-news reaction and broader biotech weakness versus options-related or short-selling pressure, while some remain cautious about revenue growth and dilution.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

XEs steep selloff and search for a bottom dominate the discussion, with traders attributing pressure to post-IPO selling, bearish analyst coverage, and weakness across nuclear stocks. Some see Amazons backing and potential SMR demand from data centers as a long-term positive, while others remain concerned that commercialization is years away.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus cancer-trial pipeline is driving attention, particularly the FDA-cleared expansion of its recurrent glioblastoma REGAIN study and completed enrollment in the pancreatic IMPACT study ahead of further data updates. Traders are broadly optimistic about these milestones, though expectations for a near-term stock move remain speculative amid price consolidation.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

ALM is drawing attention after a sharp selloff during and following its investor day, with traders criticizing CEO Lewis Blacks presentation and questioning whether it offered meaningful new information. The reaction contrasts with longer-term bullish views on Sangdongs production ramp and tungsten demand, while some attribute weakness to broader market pressure.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is drawing attention ahead of its Q3 earnings report as shares retreat amid a broader tech and AI selloff. Traders are split over whether strong ad performance and Muse AI momentum can justify heavy AI spending, with capex and returns on that investment central to expectations for the report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

H.B. Fuller Board Unanimously Rejects Second Unsolicited, Non-Binding Proposal for Building Adhesive Solutions Segment

H.B. Fuller Company (H.B. Fuller or the Company) (NYSE: FUL), the worlds largest pureplay adhesives company, today announced that following a thorough review supported by independent financial and legal advisors, its Board of Directors has unanimously rejected Ancoras second unsolicited...

H.B. Fuller Prices $850M Debt Offering to Fund AMS Acquisition

FUL prices $850M in senior notes to finance its AMS acquisition and refinance debt, with a 7.625% coupon and a key redemption condition tied to the deal.

H.B. Fuller Announces Pricing of $850 Million Debt Offering

H.B. Fuller Company (H.B. Fuller) (NYSE:FUL) announced today that it has priced an offering of $850 million aggregate principal amount of 7.625% new senior unsecured notes due 2034 (the Notes) at an issue price of 100% of the principal amount, in a private offering (the Notes Offering) that is...

H. B. Fuller (FUL) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Director Of H.B. Fuller Makes $100K Buy

On September 30, DANIEL FLORNESS, Director at H.B. Fuller (NYSE:FUL) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: In a recent Form 4 filing with the U.S. Securities andread more...

Teresa Trangsrud Rasmussen's Recent Buy: Acquires $99K In H.B. Fuller Stock

It was revealed in a recent SEC filing that Teresa Trangsrud Rasmussen, Board Member at H.B. Fuller (NYSE:FUL) made a noteworthy insider purchase on September 30,.
What Happened: In a recent Form 4 filing with the U.S.read more...

Insider Move: THOMAS HANDLEY Invests $98K In H.B. Fuller Stock

A new SEC filing reveals that THOMAS HANDLEY, Board Member at H.B. Fuller (NYSE:FUL), made a notable insider purchase on September 30,.
What Happened: HANDLEY's recent move, as outlined in a Form 4 filing with theread more...

Board Member Of H.B. Fuller Makes $100K Buy

It was revealed in a recent SEC filing that Srilata Zaheer, Board Member at H.B. Fuller (NYSE:FUL) made a noteworthy insider purchase on September 30,.
What Happened: In a recent Form 4 filing with the U.S. Securitiesread more...

Board Member Of H.B. Fuller Purchased $99K In Stock

Charles Lauber, Board Member at H.B. Fuller (NYSE:FUL), reported an insider buy on September 30, according to a new SEC filing.
What Happened: Lauber's recent move, as outlined in a Form 4 filing with the U.S.read more...

H.B. Fuller Announces Quarterly Dividend

H.B. Fuller Company (NYSE: FUL) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.2450 per share of common stock, payable on October 29, 2026 to shareholders of record at the close of business on October 15, 2026. H.B. Fuller has paid quarterly cash...

H.B. Fuller expects FY2026 net revenue up mid-single digits, organic revenue up low-single digits, adjusted EBITDA of $655M to $670M, and adjusted diluted EPS of $4.70 to $4.85.

H.B. Fuller faced lower volume despite pricing increases, higher working capital from inventory investments amid Middle East disruption, and Q3 FY2026 interest expense of $40.92M versus $33.63M.

H.B. Fuller grew revenue across all three global business units, reported adjusted EBITDA and margin growth with pricing and restructuring savings, and cited adjusted EPS growth and anticipated AMS acquisition closing.

H.B. Fuller Co. engages in the manufacture and marketing of adhesives, sealants, and other chemical products. It operates through the following business segments: Hygiene, Health, and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health, and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts, and envelope markets. The Engineering Adhesives segment provides adhesives to the transportation, electronics, medical, clean energy, aerospace and defense, performance wood, insulating glass, textile, appliance, and heavy machinery markets. The Construction Adhesives segment manufactures adhesives, sealants, tapes, mortars, and grouts for construction activities. The company was founded by Harvey Benjamin Fuller in 1887 and is headquartered in St. Paul, MN.

H.B. Fuller Company

H.B. Fuller Sees $55M Synergy Potential From AMS Deal – But Investors Are Still Selling FUL Stock 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>H.B. Fuller made a cash offer of £2.85 per share for Advanced Medical Solutions shareholders.</li><li>The company expects about $55 million in combined run-rate revenue and cost synergies by 2031.</li><li>AMS is also expected to increase H.B. Fuller’s annual revenue by roughly $300 million while creating revenue growth and EBITDA opportunities.</li></ul><p>H.B. Fuller (FUL), the world’s largest pure-play adhesives maker, on Thursday said it would acquire UK-based Advanced Medical Solutions Group Plc in a cash deal valued at £715 million&nbsp;(about $941.8 million).</p><p>At the time of writing, FUL stock was down over 6% in Thursday's premarket trading.</p><h2 class="st-heading-2"><strong>Why H.B. Fuller Is Buying AMS</strong></h2><p>H.B. Fuller, the Minnesota-based adhesive maker, said the acquisition of Advanced Medical Solutions (AMS) would broaden its portfolio and add a medical adhesives segment to its overall product offerings.</p><p>“We have long been clear that medical is a core strategic growth market for H.B. Fuller given its durable demand trends, high regulatory-based entry barriers, and margin profile. Accordingly, we have thoroughly analyzed this structurally scarce market to identify the most attractive assets and growth opportunities,” said Celeste Mastin, President and Chief Executive Officer at H.B. Fuller.</p><h2 class="st-heading-2"><strong>Why Does The Deal Matter To FUL?</strong></h2><p>The company said that the deal would grow its capabilities across tissue bonding adhesives, tapes and dressings, and formulated bio-surgicals segments and result in bringing its total addressable market to $95 billion from $80 billion.</p><p>H.B. Fuller will also be able to leverage AMS’s pan-European salesforce and create cross-selling opportunities for its current portfolio, while AMS can utilize H.B. Fuller’s U.S. infrastructure and distribution network of market leaders to accelerate U.S. penetration.</p><p>The firm noted that it expects to capture about $55 million in combined run-rate revenue and cost synergies by 2031. AMS is also expected to increase H.B. Fuller’s annual revenue by roughly $300 million while creating revenue growth and earnings before interest, taxes , depreciation and amortization (EBITDA) opportunities.&nbsp;&nbsp;</p><h2 class="st-heading-2"><strong>FUL - AMS&nbsp;Deal Contours</strong></h2><p>According to the proposed deal, each eligible AMS shareholder will get £2.85 per share in cash, implying a total enterprise value of £715 million. The transaction will be 100% financed through a committed financing, H.B. Fuller said.</p><p>The deal is expected to close by the end of this calendar year.</p><h2 class="st-heading-2"><strong>FUL Q2 Earnings Print</strong></h2><p>On Wednesday, H.B. Fuller reported second-quarter revenue of $950 million, ahead of analysts' expectations of $924 million, while adjusted earnings of $1.41 per share came in more than Wall Street estimates of $1.38, according to Fiscal.ai data.</p><h2 class="st-heading-2"><strong>What Retail Thinks Of FUL</strong></h2><p>On Stocktwits, retail sentiment surrounding the stock has remained ‘bullish’ amid ‘high’ message volumes in the past 24 hours.</p><p><a href="https://stocktwits.com/symbol/FUL">FUL stock</a> has gained over 7% so far this year.</p><p>(£1 = $1.32)</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p><p>Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/ibm-sub-1nm-chip-technology-100-billion-transistors/cZ1GgODR7Qu">IBM Just Packed 100B Transistors Into A Fingernail-Sized Sub-1nm Chip — Is It Rewriting Moore's Law?</a></p>

In this photo illustration, the H.B. Fuller company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

The Acquisition of Advanced Medical Solutions would broaden H.B. Fuller’s product portfolio and add a medical adhesives segment to its overall product offerings.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$50.72
Prev Close	$51.32
Open	$51.13
Dividend Yield	1.59%
50-Day Moving Average	$53.82
Beta	0.99
Avg. Volume	937,802.45
PE Ratio	14.29

52-Week High	$68.63
52-Week Low	$46.70
Market Capitalization	$2.76B
EPS (Annual)	$2.75
Price to Book	1.27
Revenue Per Employee	$489,237.89

Feed

News

Sentiment

Earnings

Fundamentals

Info

FUL Fundamentals